Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ocufolin Forte
- Development stage
- Preclinical
- Lead developer
- Aprofol
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ocufolin Forte is an innovative folate-based dietary supplement classified as a Food for Special Medical Purposes (FSMP), developed by the Swiss life science company Aprofol AG. Its primary active ingredient is L-methylfolate (levomefolic acid), which is delivered within a lipophilic matrix that also contains essential minerals and antioxidants. The product is specifically designed to address ocular vascular diseases by targeting elevated homocysteine (Hcy) levels and increased retinal venous pressure (RVP), both of which are significant risk factors for vision loss. Ocufolin Forte is primarily indicated for age-related macular degeneration (AMD), including neovascular AMD (nAMD), and has been investigated for its potential benefits in glaucoma and diabetic retinopathy. Clinical evidence suggests that it supports improvements in retinal microcirculation and total retinal blood flow, particularly when used as an adjunct to standard anti-VEGF therapies.
- Brand names
- Ocufolin Forte
- Other names
- Ocufolin forte
02
Targets
ET (Endothelin receptors)NOS3 (eNOS)
Beyond the preview
Go deeper on Ocufolin Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ocufolin Forte.